Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

OBJECTIVE: Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. METHODS: These questions were investigated in a case–control st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K. V., Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., Hoque, Ashraful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139891/
https://www.ncbi.nlm.nih.gov/pubmed/21667068
http://dx.doi.org/10.1007/s10552-011-9787-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139891/
https://www.ncbi.nlm.nih.gov/pubmed/21667068
http://dx.doi.org/10.1007/s10552-011-9787-7

Ejemplares similares